Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation.

Mindy VroomenBart MaesenJustin G LuermansHarry J CrijnsJos G MaessenMark La MeirLaurent Pison

Published in: Journal of interventional cardiology (2019)

Implantation of the WD seems to be feasible and safe in the setting of hybrid AF ablation and could be an alternative to epicardial occlusion in surgical AF ablation procedures. Larger studies are required to confirm these findings. This trial is registered with NCT02471131.

Keyphrases

left atrial appendage
atrial fibrillation
catheter ablation
left atrial
oral anticoagulants
direct oral anticoagulants
heart failure
percutaneous coronary intervention
clinical trial
phase iii